Status:
COMPLETED
Role of Obstructive Sleep Apnea Syndrome in the Occurrence of Diabetic Retinopathy in Type 2 Diabetes.
Lead Sponsor:
Centre Hospitalier Universitaire Saint Pierre
Conditions:
Diabetes Mellitus
Obstructive Sleep Apnea
Eligibility:
All Genders
18-90 years
Brief Summary
Diabetic retinopathy (DR) is the most common visual complication of diabetes. Risk factors for developing DR are diabetes duration, glycemic control, and hypertension . The prevalence ranges from 17 t...
Detailed Description
Diabetic retinopathy (DR) is the most common visual complication of diabetes. Risk factors for developing DR are diabetes duration, glycemic control, and hypertension. The prevalence ranges from 17 to...
Eligibility Criteria
Inclusion
- presence of diabetic type II
- able to undergo an in-lab polysomnography
Exclusion
- known presence of obstructive sleep apnea and treated by CPAP
Key Trial Info
Start Date :
October 6 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03314467
Start Date
October 6 2017
End Date
June 30 2021
Last Update
September 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Universitaire Saint Pièrre
Brussels, Belgium